GB0329617D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB0329617D0
GB0329617D0 GB0329617A GB0329617A GB0329617D0 GB 0329617 D0 GB0329617 D0 GB 0329617D0 GB 0329617 A GB0329617 A GB 0329617A GB 0329617 A GB0329617 A GB 0329617A GB 0329617 D0 GB0329617 D0 GB 0329617D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0329617A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research
Astex Technology Ltd
Cancer Research Technology Ltd
Original Assignee
Institute of Cancer Research
Astex Technology Ltd
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research, Astex Technology Ltd, Cancer Research Technology Ltd filed Critical Institute of Cancer Research
Priority to GB0329617A priority Critical patent/GB0329617D0/en
Publication of GB0329617D0 publication Critical patent/GB0329617D0/en
Priority to NZ547696A priority patent/NZ547696A/en
Priority to RSP-2010/0532A priority patent/RS51546B/en
Priority to EP04806258A priority patent/EP1706385B1/en
Priority to PT04806258T priority patent/PT1706385E/pt
Priority to US10/596,788 priority patent/US8247576B2/en
Priority to CN2004800420375A priority patent/CN1922148B/zh
Priority to EP10168024A priority patent/EP2228369A1/en
Priority to BRPI0418078A priority patent/BRPI0418078A8/pt
Priority to DK04806258.2T priority patent/DK1706385T3/da
Priority to PL04806258T priority patent/PL1706385T3/pl
Priority to RU2006126789/04A priority patent/RU2419612C2/ru
Priority to SI200431571T priority patent/SI1706385T1/sl
Priority to PCT/GB2004/005464 priority patent/WO2005061463A1/en
Priority to MEP-2010-532A priority patent/ME01934B/me
Priority to MXPA06007326A priority patent/MXPA06007326A/es
Priority to CA2548374A priority patent/CA2548374C/en
Priority to AT04806258T priority patent/ATE483689T1/de
Priority to JP2006546339A priority patent/JP4928949B2/ja
Priority to DE602004029501T priority patent/DE602004029501D1/de
Priority to AU2004303602A priority patent/AU2004303602C1/en
Priority to KR1020067014742A priority patent/KR101164258B1/ko
Priority to UAA200608166A priority patent/UA90461C2/ru
Priority to UY28946A priority patent/UY28946A1/es
Priority to NO20062633A priority patent/NO20062633L/no
Priority to IL176400A priority patent/IL176400A/en
Priority to ZA200605127A priority patent/ZA200605127B/xx
Priority to HK07103603.6A priority patent/HK1097543A1/xx
Priority to HR20100675T priority patent/HRP20100675T1/hr
Priority to CY20111100002T priority patent/CY1111493T1/el
Priority to US13/536,174 priority patent/US8691806B2/en
Priority to US14/180,440 priority patent/US9283226B2/en
Priority to US15/010,831 priority patent/US20160250187A1/en
Ceased legal-status Critical Current

Links

GB0329617A 2003-12-23 2003-12-23 Pharmaceutical compounds Ceased GB0329617D0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
GB0329617A GB0329617D0 (en) 2003-12-23 2003-12-23 Pharmaceutical compounds
UAA200608166A UA90461C2 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
CA2548374A CA2548374C (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
JP2006546339A JP4928949B2 (ja) 2003-12-23 2004-12-23 タンパク質キナーゼモジュレーターとしてのピラゾール誘導体
EP04806258A EP1706385B1 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
AT04806258T ATE483689T1 (de) 2003-12-23 2004-12-23 Pyrazolderivate als modulatoren von proteinkinase
US10/596,788 US8247576B2 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
CN2004800420375A CN1922148B (zh) 2003-12-23 2004-12-23 作为蛋白激酶调节剂的吡唑衍生物
EP10168024A EP2228369A1 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
RSP-2010/0532A RS51546B (en) 2003-12-23 2004-12-23 DERIVATI PIRAZOLA KAO MODULATORI PROTEIN KINAZE
DK04806258.2T DK1706385T3 (da) 2003-12-23 2004-12-23 Pyrazol-derivater som proteinkinasemodulatorer
PL04806258T PL1706385T3 (pl) 2003-12-23 2004-12-23 Pochodne pirazolu jako modulatory kinazy białkowej
RU2006126789/04A RU2419612C2 (ru) 2003-12-23 2004-12-23 Производные пиразола в качестве модуляторов протеинкиназы
SI200431571T SI1706385T1 (sl) 2003-12-23 2004-12-23 Pirazolni derivati kot modulatorji protein-kinaze
PCT/GB2004/005464 WO2005061463A1 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
DE602004029501T DE602004029501D1 (de) 2003-12-23 2004-12-23 Pyrazolderivate als modulatoren von proteinkinase
MXPA06007326A MXPA06007326A (es) 2003-12-23 2004-12-23 Derivados de pirazol como moduladores de proteina cinasa.
NZ547696A NZ547696A (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
PT04806258T PT1706385E (pt) 2003-12-23 2004-12-23 Derivados de pirazol como moduladores de proteína quinase
BRPI0418078A BRPI0418078A8 (pt) 2003-12-23 2004-12-23 composto ou um seu sal, solvato, tautômero ou n-óxido, uso de um composto, métodos para a profilaxia ou tratamento de um estado ou condição doentia mediada pela proteína quinase b e mediada pela proteína quinase a, para tratar uma doença ou condição, para inibir uma proteína quinase b e uma proteína quinase a, para modular um processo celular, para tratar um distúrbio imune em um mamífero e para induzir apoptose em uma célula cancerosa, composição farmacêutica, e, processo para a preparação de um composto
MEP-2010-532A ME01934B (me) 2003-12-23 2004-12-23 Derivati pirazola kao modulatori protein kinaze
AU2004303602A AU2004303602C1 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators
KR1020067014742A KR101164258B1 (ko) 2003-12-23 2004-12-23 단백질 키나아제 조절제로서의 피라졸 유도체
UY28946A UY28946A1 (es) 2003-12-23 2005-06-08 Compuestos de aril-y heteroaril-alquilanina que contienen pirazol, composiciones farmacéuticas que contienen los compuestos y nuevos productos químicos intermedios
NO20062633A NO20062633L (no) 2003-12-23 2006-06-08 Pyrazolderivater som proteinkinasemodulatorer
IL176400A IL176400A (en) 2003-12-23 2006-06-19 Pyrazole derivatives as protein kinase modulators
ZA200605127A ZA200605127B (en) 2003-12-23 2006-06-21 Pyrazole derivatives as protein kinase modulators
HK07103603.6A HK1097543A1 (en) 2003-12-23 2007-04-03 Pyrazole derivatives as protein kinase modulators
HR20100675T HRP20100675T1 (hr) 2003-12-23 2010-12-07 Derivati pirazola kao modulatori protein kinaze
CY20111100002T CY1111493T1 (el) 2003-12-23 2011-01-03 Παραγωγα πυραζολιου ως τροποποιητες πρωτεϊνοκινασης
US13/536,174 US8691806B2 (en) 2003-12-23 2012-06-28 Pyrazole derivatives as protein kinase modulators
US14/180,440 US9283226B2 (en) 2003-12-23 2014-02-14 Pyrazole derivatives as protein kinase modulators
US15/010,831 US20160250187A1 (en) 2003-12-23 2016-01-29 Pyrazole derivatives as protein kinase modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0329617A GB0329617D0 (en) 2003-12-23 2003-12-23 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB0329617D0 true GB0329617D0 (en) 2004-01-28

Family

ID=30776233

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0329617A Ceased GB0329617D0 (en) 2003-12-23 2003-12-23 Pharmaceutical compounds

Country Status (11)

Country Link
CN (1) CN1922148B (sl)
AT (1) ATE483689T1 (sl)
DE (1) DE602004029501D1 (sl)
DK (1) DK1706385T3 (sl)
GB (1) GB0329617D0 (sl)
ME (1) ME01934B (sl)
PT (1) PT1706385E (sl)
RS (1) RS51546B (sl)
SI (1) SI1706385T1 (sl)
UA (1) UA90461C2 (sl)
ZA (1) ZA200605127B (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0704932D0 (en) * 2007-03-14 2007-04-25 Astex Therapeutics Ltd Pharmaceutical compounds
CN108339121A (zh) * 2017-01-25 2018-07-31 苏州大学 蛋白激酶a抑制剂在制备治疗血小板数量增多相关疾病药物中的用途
CN111056990B (zh) * 2019-12-16 2022-06-17 爱斯特（成都）生物制药股份有限公司 一种合成1-叔丁氧羰基-4-(4-羧基苯基)哌啶的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804734D0 (en) * 1998-03-05 1998-04-29 Pfizer Ltd Compounds
KR20020091829A (ko) * 1999-07-30 2002-12-06 애보트 게엠베하 운트 콤파니 카게 2-피라졸린-5-온

Also Published As

Publication number Publication date
UA90461C2 (en) 2010-05-11
ME01934B (me) 2011-06-30
RS51546B (en) 2011-06-30
PT1706385E (pt) 2010-12-22
DK1706385T3 (da) 2011-01-10
ATE483689T1 (de) 2010-10-15
SI1706385T1 (sl) 2011-01-31
CN1922148A (zh) 2007-02-28
CN1922148B (zh) 2012-03-21
ZA200605127B (en) 2010-07-28
DE602004029501D1 (de) 2010-11-18

Similar Documents

Publication Publication Date Title
EG27104A (en) Pharmaceutical compounds
GB0315657D0 (en) Pharmaceutical compounds
GB0218625D0 (en) Pharmaceutical compounds
GB0324886D0 (en) Medicinal compounds
GB0303396D0 (en) Medicinal compounds
GB0308511D0 (en) Pharmaceutical compounds
HU0301154D0 (en) Pharmaceutical composition
GB0300427D0 (en) Pharmaceutical composition
GB0215775D0 (en) Pharmaceutical compounds
EP1778252A4 (en) NON-CARDIOTOXIC PHARMACEUTICAL COMPOUNDS
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (en) PHARMACEUTICAL COMPOSITION
GB0329232D0 (en) Pharmaceutical composition
GB0317663D0 (en) Pharmaceutical composition
GB0317315D0 (en) Pharmaceutical compounds
GB0328490D0 (en) Medicinal compounds
GB0300885D0 (en) Pharmaceutical composition
GB0301736D0 (en) Pharmaceutical compounds
GB0313766D0 (en) Pharmaceutical compounds
GB2401043B (en) Drug
GB0316889D0 (en) Pharmaceutical agents
GB0306933D0 (en) Pharmaceutical composition
GB0329617D0 (en) Pharmaceutical compounds
GB0307869D0 (en) Pharmaceutical composition
GB0310361D0 (en) Pharmaceutical compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)